New drug HWK-007 targets Hard-to-Treat cancers in early trial
NCT ID NCT07444814
First seen Jun 27, 2026 · Last updated Aug 06, 2026 · Updated 2 times
Summary
This early-stage study tests a new drug called HWK-007 in people with advanced solid tumors, including certain ovarian, endometrial, and lung cancers. The drug is designed to target a protein (PTK7) found on cancer cells and deliver a chemotherapy-like payload directly to them. The main goals are to find the safest dose and check for side effects. About 226 adults will take part, and the study is currently recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fred Hutchinson Cancer Center
NOT_YET_RECRUITINGSeattle, Washington, 98109, United States
-
Hackensack University Medical Center - John Theurer Cancer Center
RECRUITINGHackensack, New Jersey, 07601, United States
-
NEXT - Oncology - Houston
RECRUITINGHouston, Texas, 77054, United States
-
NEXT Oncology - Austin
RECRUITINGAustin, Texas, 78758, United States
-
NEXT Oncology - Virginia Cancer Specialists
RECRUITINGFairfax, Virginia, 22031, United States
-
Roswell Park Comprehensive Care Center
RECRUITINGBuffalo, New York, 14263, United States
-
START - Midwest
RECRUITINGGrand Rapids, Michigan, 49546, United States
-
START - San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
-
St. Francis Medical Center (OSF Healthcare)
RECRUITINGPeoria, Illinois, 61637, United States
-
UCLA - Hematology/Oncology Clinical Research Unit
NOT_YET_RECRUITINGLos Angeles, California, 90095, United States
-
University Hospital - Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
-
University of Arkansas
RECRUITINGLittle Rock, Arkansas, 72205-7199, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?